Records containing: Open-angle Glaucoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2019-05-01A Prospective, Double-masked, Randomized, Multi-center, Active Controlled, Parallel-group, 3-month Study Assessing the Safety and Ocular Hypotensive Efficacy of PG324 Ophthalmic Solution Compared to AR-13324 Ophthalmic Solution 0.02% and Latanoprost Ophthalmic Solution 0.005% in Subjects With Elevated Intraocular Pressure
-
CLINICAL_TRIALS study record update · 2018-04-18ClinicalTrials.gov study NCT02179008
-
CLINICAL_TRIALS study record update · 2018-04-13A Double-masked, Randomized, Multi-center, Active-controlled, Parallel, 3-month Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-13324 Ophthalmic Solution, 0.02% Compared to Timolol Maleate Ophthalmic Solution, 0.5% in Patients With Elevated Intraocular Pressure
-
CLINICAL_TRIALS study record update · 2018-04-06A Double-masked, Randomized, Multi-center, Active-controlled, Parallel, 12-month Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-13324 Ophthalmic Solution, 0.02% q.d. and b.i.d. Compared to Timolol Maleate Ophthalmic Solution, 0.5% b.i.d. in Patients With Elevated Intraocular Pressure
-
CLINICAL_TRIALS study record update · 2018-04-06A Double-masked, Randomized, Multi-center, Active-controlled, Parallel Group, 6-month Study With a 3-month Interim Analysis Assessing the Ocular Hypotensive Efficacy and Safety of AR-13324 Ophthalmic Solution, 0.02% QD Compared to Timolol Maleate Ophthalmic Solution, 0.5% BID in Patients With Elevated Intraocular Pressure
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2017-12-18A Prospective, Randomized Evaluation of Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent) or Travoprost Ophthalmic Solution 0.004%
-
CLINICAL_TRIALS study record update · 2017-05-05ClinicalTrials.gov study NCT01298687
-
CLINICAL_TRIALS study record update · 2017-01-10The Expression of Matrix Metalloproteinase 13（MMP13）, Tissue Inhibitor of Metalloproteinases 3（TIMP13）, and Calcium-sensing Receptor（CaSR） in Human Trabecular Meshwork
-
CLINICAL_TRIALS study record update · 2016-11-22Dose, Effects and Characteristics of Pilocarpine
-
CLINICAL_TRIALS study record update · 2016-11-22ClinicalTrials.gov study NCT00759239
-
CLINICAL_TRIALS study record update · 2016-11-18A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
-
CLINICAL_TRIALS study record update · 2016-11-18ClinicalTrials.gov study NCT00314158
-
CLINICAL_TRIALS study record update · 2016-11-18A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
-
CLINICAL_TRIALS study record update · 2016-11-18ClinicalTrials.gov study NCT00293761
-
CLINICAL_TRIALS study record update · 2015-04-08Non-invasive Absolute Intracranial Pressure (ICP) Measurement in Patients With Open-angle Glaucoma and Papilledema
-
CLINICAL_TRIALS study record update · 2014-07-31ClinicalTrials.gov study NCT01781962
-
CLINICAL_TRIALS study record update · 2014-07-24Compliance Study Comparing DuoTrav to TRAVATAN Plus Timolol Using the Dosing Aid
-
CLINICAL_TRIALS study record update · 2014-07-18A Twelve-Month Open-Label Safety Study of Polyquaternium-Preserved DuoTrav APS Dosed Once Daily in Patients With Open-Angle Glaucoma or Ocular Hypertension
-
CLINICAL_TRIALS study record update · 2014-07-10Comparison of Safety and IOP-Lowering Efficacy of Three Alternative Travoprost Formulations to Vehicle and TRAVATAN® in Patients With Open-Angle Glaucoma or Ocular Hypertension
-
CLINICAL_TRIALS study record update · 2014-07-01Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on COMBIGAN® (Brimonidine 0.2%/Timolol 0.5% Fixed Combination) Therapy in Canada
-
CLINICAL_TRIALS study record update · 2014-06-13Multi-Center Study Comparing Efficacy and Tolerability of TRAVATAN® BAK-free (0.004% Travoprost) in Patients Previously on Latanoprost Ophthalmic Solution 0.005% Monotherapy
-
CLINICAL_TRIALS study record update · 2014-03-06A Prospective, Randomized, Controlled, Parallel Groups, Multicenter Clinical Investigation Of The Trabecular Micro-Bypass Stent Model GTS400 In Conjunction With Cataract Surgery
-
CLINICAL_TRIALS study record update · 2013-10-25A Proof of Concept Study to Assess the Safety and IOP-Lowering Effect of AL-59412C Injected Intravitreally
-
CLINICAL_TRIALS study record update · 2013-05-14A Multicenter Study of the Pigmentation in the Trabecular Meshwork After Two Years of Treatment With TRAVATAN 0.004% Ophthalmic Solution
-
CLINICAL_TRIALS study record update · 2013-03-28ClinicalTrials.gov study NCT00872651